Regarding NASH, it looks like the FDA is no longer
Post# of 148292
(Total Views: 933)
Posted On: 01/26/2021 2:27:01 PM
Regarding NASH, it looks like the FDA is no longer requiring them to study and "evaluate the safety [and] tolerability" of Leronlimab, nor are they requiring them to compare dosages between "525 mg or 700 mg dose," it's all 700 mg now.
Looks like the FDA is now satisfied that Leronlimab is safe and tolerable and that the 700 dose is the correct one, if I am reading this all correctly.
https://clinicaltrials.gov/ct2/history/NCT045...udyPageTop
Looks like the FDA is now satisfied that Leronlimab is safe and tolerable and that the 700 dose is the correct one, if I am reading this all correctly.
https://clinicaltrials.gov/ct2/history/NCT045...udyPageTop
(16)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼